Edwards Lifesciences exec sells 17,968 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Edwards Lifesciences Corp executive Donald E. Bobo Jr., CVP of Strategy and Corporate Development, reported open-market sales of company common stock. On May 15, 2026, he sold 8,000 shares indirectly through a 401(k) account at $81.8216 per share and 9,968 shares directly at $82.0732 per share. A footnote notes the directly held sale was executed in multiple trades with prices ranging from $81.975 to $82.260, and the reported price is a weighted average. After these transactions, he held 22,798.2532 shares directly, 30,969.5756 shares indirectly via the 401(k), and 121,756 shares indirectly in a trust.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 9,968 | $82.0732 | $818K |
| Sale | Common Stock | 8,000 | $81.8216 | $655K |
| Holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. This transaction was executed in multiple trades at prices ranging from $81.975 to $82.260. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Key Terms
open-market sale financial
weighted average sale price financial
401(k) financial
By Trust financial
indirect financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Edwards Lifesciences (EW) executive Donald Bobo Jr. report in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.